FindTrial
Sign In

Multiparametric MRI Radiomics for Predicting Malignant Risk in Meningiomas

Multiparametric MRI Radiomics for Predicting Malignant Risk in Meningiomas

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600118475
Enrollment
Unknown
Registered
2026-02-06
Start date
2026-02-10
Completion date
Unknown
Last updated
2026-02-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

meningioma

Interventions

Observation group:None

Sponsors

The Second Affiliated Hospital of Hainan Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1.Underwent preoperative plain and enhanced craniocerebral MRI; 2. Pathologically confirmed WHO grade and Ki-67 index of the lesion; 3. No history of any prior antitumor therapy.

Exclusion criteria

Exclusion criteria: 1.Prior history of radiotherapy or chemotherapy; 2. Poor MRI image quality with significant artifacts and interference, unsuitable for the study requirements; 3. Presence of contraindications to treatment or relevant examinations.

Design outcomes

Primary

MeasureTime frame
Area Under the Curve;Ki-67 index;WHO grading;—

Countries

China

Contacts

Public ContactDai Ganmian

The Second Affiliated Hospital of Hainan Medical University

c670240689@163.com+86 177 6389 0479

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 15, 2026